相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia
Melanie Maerklin et al.
NATURE COMMUNICATIONS (2017)
Chronic lymphocytic leukaemia
Thomas J. Kipps et al.
Nature Reviews Disease Primers (2017)
Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemia
Michaela Wagner et al.
BLOOD (2016)
Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL
Annalisa D'Avola et al.
BLOOD (2016)
Recent advances in therapy of chronic lymphocytic leukaemia
David J. M. Routledge et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade
Sarah E. M. Herman et al.
SEMINARS IN ONCOLOGY (2016)
Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL
Stefano Iacovelli et al.
BLOOD (2015)
The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia
Adrian Wiestner
HAEMATOLOGICA (2015)
Expression of Functional Sphingosine-1 Phosphate Receptor-1 Is Reduced by B Cell Receptor Signaling and Increased by Inhibition of PI3 Kinase δ but Not SYK or BTK in Chronic Lymphocytic Leukemia Cells
Kathleen J. Till et al.
JOURNAL OF IMMUNOLOGY (2015)
The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia
Adrian Wiestner
HAEMATOLOGICA (2015)
Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era
Chadi Nabhan et al.
JAMA ONCOLOGY (2015)
Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function
Vania Coelho et al.
BLOOD (2013)
Egress of CD19+CD5+ cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients
Betty Y. Chang et al.
BLOOD (2013)
In Vitro Sensitivity of CLL Cells to Fludarabine May Be Modulated by the Stimulation of Toll-like Receptors
Eleonora Fonte et al.
CLINICAL CANCER RESEARCH (2013)
T/B ratio does not reflect levels of ZAP70 expression in clonal CLL B-cells due to ZAP70 overexpression in patient T-cells
David Rizzo et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2013)
Proteomic analysis of B-cell receptor signaling in chronic lymphocytic leukaemia reveals a possible role for kininogen
Elena Kashuba et al.
JOURNAL OF PROTEOMICS (2013)
LCK Is an Important Mediator of B-Cell Receptor Signaling in Chronic Lymphocytic Leukemia Cells
Fatima Talab et al.
MOLECULAR CANCER RESEARCH (2013)
Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia
S. E. M. Herman et al.
LEUKEMIA (2013)
Expression levels of Lyn, Syk, PLCγ2 and ERK in patients with chronic lymphocytic leukemia, and higher levels of Lyn are associated with a shorter treatment-free survival
Yin-Hua Wang et al.
LEUKEMIA & LYMPHOMA (2013)
Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signaling
Shih-Shih Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia
Martin F. M. de Rooij et al.
BLOOD (2012)
Expansion of a CD8+PD-1+ Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression
Claudia Nunes et al.
CLINICAL CANCER RESEARCH (2012)
Glucocorticoid resistance in chronic lymphocytic leukaemia is associated with a failure of upregulated Bim/Bcl-2 complexes to activate Bax and Bak
T. Melarangi et al.
CELL DEATH & DISEASE (2012)
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Sarah E. M. Herman et al.
BLOOD (2011)
B-cell receptor signaling in chronic lymphocytic leukemia
Freda K. Stevenson et al.
BLOOD (2011)
Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70-
Daniel O. Griffin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL
J. Pinon Hofbauer et al.
LEUKEMIA (2011)
Surface IgM of CLL cells displays unusual glycans indicative of engagement of antigen in vivo
Sergey Krysov et al.
BLOOD (2010)
Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia
M. W. Harr et al.
CELL DEATH AND DIFFERENTIATION (2010)
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
Lee A. Honigberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Spleen Tyrosine Kinase Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia
Maike Buchner et al.
CANCER RESEARCH (2009)
ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia
Liguang Chen et al.
BLOOD (2008)
Temporal genetic program following B-cell receptor cross-linking: altered balance between proliferation and death in healthy and malignant B cells
Laurent D. Vallat et al.
BLOOD (2007)
ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells
Stefania Gobessi et al.
BLOOD (2007)
B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia
Xiao-jie Yan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
c-Abl expression in chronic lymphocytic leukemia cells: Clinical and therapeutic implications
Ke Lin et al.
CANCER RESEARCH (2006)
The tyrosine kinase Lck is a positive regulator of the mitochondrial apoptosis pathway by controlling Bak expression
AK Samraj et al.
ONCOGENE (2006)
B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia
DJ Allsup et al.
CANCER RESEARCH (2005)
T-cell ZAP-70 overexpression in chronic lymphocytic leukemia (CLL) correlates with CLL cell ZAP-70 levels, clinical stage and disease progression
Y Herishanu et al.
LEUKEMIA (2005)
Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells
A Petlickovski et al.
BLOOD (2005)
Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity
M Hervé et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
ZAP-70 directly enhances TgM signaling in chronic lymphocytic leukemia
LG Chen et al.
BLOOD (2005)
Regulation of BCR signal transduction in B-1 cells requires the expression of the Src family kinase Lck
JM Dal Porto et al.
IMMUNITY (2004)
Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia
BT Messmer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B
RS Boyd et al.
LEUKEMIA (2003)
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile
A Wiestner et al.
BLOOD (2003)
Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia
S Lanham et al.
BLOOD (2003)
Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia
LG Chen et al.
BLOOD (2002)
Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion
Y Aalto et al.
LEUKEMIA (2001)
分享论文
